
SINT Stock Forecast & Price Target
SINT Analyst Ratings
Bulls say
SINTX Technologies Inc. is positioned for significant growth, driven by their successful NPV analysis which indicates considerable upside potential from current share prices. The company's focus on biomedical commercialization and a recent strategic acquisition further enhance its financial outlook, promoting a promising trajectory in diversified applications. Additionally, the anticipated expansion of the global antimicrobial fertilizer and crop protection market, projected to reach $10 billion by 2030, presents further opportunities for SINTX Technologies to capitalize on its innovative materials and technologies.
Bears say
SINTX Technologies Inc. reported a significant net loss of $10.3 million, or an earnings per share (EPS) of $(3.46), which greatly exceeded prior estimates and reflects ongoing operational challenges. The company has also faced consistent net losses, with an additional $2.3 million in losses recorded at an EPS of $(0.91) for previous periods, indicating a trend of underperformance relative to expectations. Moreover, multiple risks have been identified that could hinder the company's growth prospects, including liquidity concerns, potential regulatory setbacks, and difficulties in product commercialization, all of which could adversely impact investor sentiment and financial stability.
This aggregate rating is based on analysts' research of SINTX Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.
SINT Analyst Forecast & Price Prediction
Start investing in SINT
Order type
Buy in
Order amount
Est. shares
0 shares